• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure.

作者信息

Sinha Anil-Martin, Filzmaier Karsten, Breithardt Ole-Alexander, Kunz Dagmar, Graf Jürgen, Markus Kai U, Hanrath Peter, Stellbrink Christoph

机构信息

Department of Cardiology, University Hospital Aachen, Aachen, Germany.

出版信息

Am J Cardiol. 2003 Mar 15;91(6):755-8. doi: 10.1016/s0002-9149(02)03425-2.

DOI:10.1016/s0002-9149(02)03425-2
PMID:12633819
Abstract
摘要

相似文献

1
Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure.脑钠肽释放作为心力衰竭患者长期心脏再同步治疗疗效替代标志物的效用
Am J Cardiol. 2003 Mar 15;91(6):755-8. doi: 10.1016/s0002-9149(02)03425-2.
2
Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.心脏再同步治疗植入时右向左心室激活延迟时间延长与左束支传导阻滞患者临床结局改善相关。
Europace. 2016 Apr;18(4):550-9. doi: 10.1093/europace/euv117. Epub 2015 Jun 27.
3
Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure.完全性左束支传导阻滞和较小的左心房是晚期心力衰竭患者对心脏再同步治疗反应的预测指标。
Circ J. 2015;79(11):2414-21. doi: 10.1253/circj.CJ-15-0769. Epub 2015 Sep 17.
4
Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.根据基线变量及早期反应预测心脏再同步治疗对死亡率的长期影响——来自CARE-HF（心力衰竭心脏再同步治疗）试验的报告
J Am Coll Cardiol. 2008 Aug 5;52(6):438-45. doi: 10.1016/j.jacc.2008.04.036.
5
Prognostic value of B-type natriuretic peptide in patients with left bundle-branch block admitted for acute heart failure.
Eur J Intern Med. 2011 Dec;22(6):e152-4. doi: 10.1016/j.ejim.2011.07.020. Epub 2011 Sep 1.
6
Biventricular pacing worsened dyssynchrony in heart failure patient with right-bundle branch block.双心室起搏加重了伴有右束支传导阻滞的心力衰竭患者的不同步性。
Int J Cardiol. 2010 Feb 4;138(3):e47-50. doi: 10.1016/j.ijcard.2008.06.063. Epub 2008 Aug 15.
7
Cardiac resynchronization therapy and the electrical substrate in heart failure: what does the QRS conceal?心脏再同步治疗与心力衰竭中的电基质：QRS波隐藏了什么？
Heart Rhythm. 2009 Jul;6(7):1059-62. doi: 10.1016/j.hrthm.2009.03.052. Epub 2009 Mar 31.
8
Cardiac resynchronization therapy in patients with narrow QRS.窄QRS波患者的心脏再同步治疗
J Am Coll Cardiol. 2004 Nov 16;44(10):2096; author reply 2096-7. doi: 10.1016/j.jacc.2004.08.025.
9
Regional correlation by color-coded tissue Doppler to quantify improvements in mechanical left ventricular synchrony after biventricular pacing therapy.
Am J Cardiol. 2003 Sep 15;92(6):752-5. doi: 10.1016/s0002-9149(03)00848-8.
10
Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months.心脏再同步治疗开始后早期血浆B型利钠肽的降低预示着12个月时的临床改善。
Eur J Heart Fail. 2006 Dec;8(8):832-40. doi: 10.1016/j.ejheart.2006.02.006. Epub 2006 Mar 6.

引用本文的文献

1
Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.心脏再同步治疗一年后左心室逆向重构和脑钠肽水平的联合预测长期临床结局。
PLoS One. 2019 Jul 17;14(7):e0219966. doi: 10.1371/journal.pone.0219966. eCollection 2019.
2
Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients.心脏再同步治疗患者中脑钠肽和肌钙蛋白水平与预后的关系
Pacing Clin Electrophysiol. 2015 May;38(5):581-90. doi: 10.1111/pace.12610. Epub 2015 Mar 30.
3
Cardiac resynchronization therapy for left ventricular dysfunction induced by chronic right ventricular pacing in a child.
心脏再同步治疗儿童慢性右心室起搏引起的左心室功能障碍。
J Korean Med Sci. 2010 Dec;25(12):1809-13. doi: 10.3346/jkms.2010.25.12.1809. Epub 2010 Nov 24.
4
SmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design.智能延迟确定的房室优化：心脏再同步治疗中使用的房室延迟方法比较（SMART-AV）：原理与设计
Pacing Clin Electrophysiol. 2010 Jan;33(1):54-63. doi: 10.1111/j.1540-8159.2009.02581.x. Epub 2009 Oct 10.
5
Biomarkers in heart failure: a clinical review.心力衰竭的生物标志物：临床综述。
Heart Fail Rev. 2010 Jul;15(4):251-73. doi: 10.1007/s10741-008-9123-9. Epub 2008 Dec 3.
6
[Electrotherapy of cardiac failure].
Internist (Berl). 2007 Sep;48(9):961-70. doi: 10.1007/s00108-007-1922-x.
7
Resynchronization therapy in the context of atrial fibrillation: benefits and limitations.
J Interv Card Electrophysiol. 2007 Apr;18(3):225-32. doi: 10.1007/s10840-007-9092-2. Epub 2007 Apr 21.
8
[Are neurohumoral parameters predictive for the efficacy of cardiac resynchronization therapy? The role of natriuretic peptides].[神经体液参数能否预测心脏再同步治疗的疗效？利钠肽的作用]
Herzschrittmacherther Elektrophysiol. 2006;17 Suppl 1:I51-5. doi: 10.1007/s00399-006-1108-6.
9
Biventricular pacing reduces ventricular arrhythmic burden and defibrillator therapies in patients with heart failure.双心室起搏可减轻心力衰竭患者的室性心律失常负担并减少除颤治疗。
Clin Cardiol. 2006 Feb;29(2):74-7. doi: 10.1002/clc.4960290208.
10
B-type natriuretic peptide: a role in selection and follow up of the implantable cardioverter-defibrillator patient?B型利钠肽：在植入式心脏复律除颤器患者的选择和随访中发挥作用？
Heart. 2006 Feb;92(2):147-8. doi: 10.1136/hrt.2005.070888.